Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
Cafazzo v. Central Medical Health Services, Inc. (1995)
Canadian pharmacies
case citation and analysis
Cazes v. Raisinger (1983)
See change being effected (CBE) supplement New Drug Approval The Road to an Approved New Drug Application Drug Price Competition and Patent Term Restoration Act of 1984 See change being effected (CBE) supplement Whether FDA-Approved Labeling Preempts State Product Liability Actions
Center for Biologics Evaluation and Research, FDA
Center for Drug Evaluation and Research (CDER), FDA
Centers for Medicare and Medicaid Services (CMS) laws made by Background
central fill pharmacy
Certificate of Registration application for revocation of - Daniel Family Pharmacy
certification requirements, electronic transmission prescriptions
See current good manufacturing practices (CGMP) Cosmetics Defining and Distinguishing Drugs from Foods, Dietary Supplements, Devices, and Cosmetics Drug Quality and Security Act of 2013 FDAMA's Compounding Provisions (§ 503A): Later Reinstated as § 503A Under the DQSA Pharmacy Compounding vs Manufacturing Adulteration Current Good Manufacturing Practice Dietary Supplements vs Drugs Drug Quality and Security Act of 2013 Medical Devices See current good manufacturing practices (CGMP)
change being effected (CBE) supplement The Road to an Approved New Drug Application Whether FDA-Approved Labeling Preempts State Product Liability Actions
Cackowski v. Wal-Mart Stores, Inc. (2000)
Camara v. Municipal Court (1967)
Candidate for Certified Pharmacy Technician
causation, malpractice
Center for Devices and Radiological Health, FDA
Centocor, Inc. v. Hamilton et al. (2012)
Central Hudson Gas v. Public Service Commission (1980)
chart orders
child-resistant containers
citizenship requirements, licensing
civil law, overview
claims Dietary Supplement Health and Education Act 1994 False Claims Act health/disease false advertising food health claims
classification system schedule I drugs schedule III drugs schedule V drugs Schedule I (Drugs and Other Substances) schedule II drugs schedule IV drugs
clinical trials application for registration investigational drugs, access to registration requirements informed consent Investigational New Drug (IND) application
See consumer medication information (CMI) Approved Drugs for Off-Label (Unlabeled) Indications See consumer medication information (CMI) Prescription Drug Labeling Information for the Patient Useful Written Patient Information and Medication Guides
CMS
Cohen v. Missouri Board of Pharmacy (1998)